Skip to main content

The Children’s Mercy Research Institute

A Research Center for Children

The Children’s Mercy Research Institute (CMRI) integrates research and clinical care with multidisciplinary teams at the point of care while bringing together nationally recognized expertise in genomic medicine, precision therapeutics, population health and health care innovation.

As a result, we accelerate the development of groundbreaking individualized therapies and treatments that transform the potential of all children, one child at a time. 


Dr. Jeffrey Colvin Receives Grant to Investigate Differences in Sudden Unexpected Infant Death by Age

Jeffrey Colvin, MD, FAAP, Pediatrics, received a 2-year, $70,000 grant award from the American SIDS Institute for his study “Using Machine Learning to Differentiate Mechanisms of SUPC from Other SUID Deaths”.

Learn more

Children’s Mercy Research Institute Annual Report

You can find a summary of the Children’s Mercy Kansas City Research Institute’s accomplishments and celebrations in FY22 (July 1, 2021-June 20, 2022) in our annual report.

Read the Report
Gift box icon

Make a Gift

Donors like you help support the research discoveries of tomorrow.

Join us!

We are looking for volunteers to be a part of the Family and Community Research Advisory Board.

Two brothers with their arm around one another

Genomic Answers for Kids

Thousands of genetic diseases affecting children remain undiscovered and untreatable. But hope is on the horizon with Genomic Answers for Kids, a first-of-its-kind pediatric data repository to find novel treatments for pediatric genetic conditions.

Discover more
Researcher at Children's Mercy

The CMRI’s Commitment to Inclusion and Diversity

Inclusion and diversity among research teams, participants, families, vendors and community partners is essential to fulfilling our mission to improve the health and wellbeing of children everywhere.

Discover more
Colorful graphic of a molecule

Researcher Network

Learn about the dynamic research programs and explore potential collaborations with our world-renown investigators.